Alternate mechanism(s) of action of the CD200:CD200 blockade in an AML model suggests a role for the augmented cytotoxicity of cytokine-induced killer cells against human myeloid leukemia blasts [42]—see also Figure 2 above. The gene discussed is CD200; the disease is acute myeloid leukemia.